01 8Opsumit
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 1,639
2019 Revenue in Millions : 1,327
Growth (%) : 24
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 1,819
2020 Revenue in Millions : 1,639
Growth (%) : 11
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 1,783
2021 Revenue in Millions : 1,819
Growth (%) : -2
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 1,973
2022 Revenue in Millions : 1,783
Growth (%) : 11
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2016 Revenue in Millions : 823
2015 Revenue in Millions : 511
Growth (%) : 61
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 573
2016 Revenue in Millions : 878
Growth (%) : -35
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 1,215
2017 Revenue in Millions : 573
Growth (%) : 112%
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 1,327
2018 Revenue in Millions : 1,215
Growth (%) : 9
LOOKING FOR A SUPPLIER?